Intraventricular pentosan polysulphate in human prion disease: An observational study in the UK

Bone, I., Belton, L., Walker, A. and Darbyshire, J. (2008) Intraventricular pentosan polysulphate in human prion disease: An observational study in the UK. European Journal of Neurology, 15(5), pp. 458-464. (doi: 10.1111/j.1468-1331.2008.02108.x)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1111/j.1468-1331.2008.02108.x

Abstract

Background, purpose and methods: This observational study assessed the effect of continuous intraventricular infusion of pentosan polysulphate (PPS) in seven patients at different clinical centres in the UK. Results: Complications of intraventricular catheterization were frequent. PPS was well-tolerated over a wide dose range (11-110 mu g/kg/day) during the 6-month study. Four patients were assessed for the entire study period: one remained stable, two showed minimal deterioration and one progressed significantly. Conclusion: Mean survival of all patients was longer than reported values for natural history of specific prion disorders. Possible reasons for these findings are explored.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Bone, Professor Ian
Authors: Bone, I., Belton, L., Walker, A., and Darbyshire, J.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:European Journal of Neurology
ISSN:1351-5101

University Staff: Request a correction | Enlighten Editors: Update this record